HEERLEN, Netherlands, Nov. 19, 2021 /PRNewswire/ -- Royal DSM, a global purpose-led science-based company, today announces that it has received a positive European Food Safety Agency (EFSA) opinion for the use of its novel methane-reducing feed additive for ruminants, Bovaer®, in the European Union. The EFSA opinion confirms that the feed additive reduces enteric methane emissions from dairy cows and is safe for the animal and the consumer. This opinion progresses the application to the final stage of approval from the European Commission Standing Committee on Plants, Animals, Food and Feed.
Bovaer® is the result of a decade of scientific research, including more than 50 peer-reviewed studies published in independent scientific journals and 45 on-farm trials in 13 countries across 4 continents. Since receiving full regulatory approvals in Brazil and Chile for Bovaer® in early September 2021, DSM has signed a development agreement with JBS S.A., one of the world's largest food producers. European Commission approval would allow DSM to start market development in Europe in the first half of 2022. DSM has already begun engineering for a new large scale production facility in Dalry, Scotland.
During the recent UN Climate Change Conference, COP26, governments of more than 100 countries pledged to cut methane emissions by 30% by 2030. Reducing methane, which is much more potent than carbon dioxide, was emphasized as a crucial way to keep within the Paris Agreement target of no more than 1.5 degrees Celsius of global warming.
Ivo Lansbergen, DSM's President, Animal Nutrition and Health, commented: "It is very timely, after the IPCC's climate change report and the recent Global Methane Pledge during COP26, that a positive opinion has been given for a feed additive that we know can have such a beneficial environmental impact. We see the livestock sector recognizes this opportunity for change and is eager to act. We are hopeful that the European Commission will approve the application with speed so that we can offer a scientifically proven effective answer to the challenge of farming's methane emissions."
DSM recently launched a series of new quantifiable commitments aimed to address urgent societal and environmental challenges linked to how the world produces and consumes food. DSM's Food System Commitments include a double-digit on-farm reduction of livestock emissions by 2030. The market introduction of Bovaer® is a major step toward delivering on this commitment as well as the strategic initiative of DSM's Animal Nutrition & Health business, We Make it Possible, with its mission to lead a robust and achievable transformation worldwide in sustainable animal protein production.
About Bovaer® Bovaer® is a feed additive for cows researched and developed over 10 years by DSM. Just a quarter teaspoon of Bovaer® per cow per day consistently reduces enteric methane emission by approximately 30% for dairy cows and even higher percentages (up till 90%) for beef cows. The feed additive Bovaer® therefore contributes to a significant and immediate reduction of the environmental footprint of meat, milk and dairy products. Bovaer® is the most extensively studied and scientifically proven solution to the challenge of burped methane to date. Upon feeding, it takes effect immediately.
DSM Royal DSM is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. DSM's purpose is to create brighter lives for all. DSM's products and solutions address some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM and its associated companies employ approximately 23,000 people around the world and deliver annual net sales of about €10 billion. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
Forward-looking statements This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.